Preclinical Pipeline

We intend to leverage our proprietary drug discovery platform to advance additional drug candidates into clinical development. Our discovery programs are focused on kinases critical to autophagy and cancer cell metabolism and kinases known to selectively drive cancer cell growth and survival. We are advancing the preclinical development of additional programs and expect to initiate further preclinical studies to continue to fulfill our mission to defeat cancer.